Inhibition of Trypsin and Chymotrypsin by Anti-Inflammatory Triterpenoids from Compositae Flowers

 

 Buy Article Permissions and Reprints

Abstract

Taraxastane, oleanane, ursane, lupane, taraxane, cycloartane, dammarane and tirucallane triterpenoids isolated from flowers of Compositae plants have been previously reported to exhibit anti-inflammatory effects and are variously competitive and non-competitive inhibitors of the serine proteases trypsin and chymotrypsin. The general features of those triterpenoids found to be protease inhibitors are having a hydroxy group and an appropriate side chain in the region of the molecule distal to the 3-hydroxy group. However, fatty acid esterification of the triterpenoid 3-hydroxy group can have a marked effect on inhibitor effectiveness. This suggests a possible means of rapid alteration of the plant defensive complement in vivo and of the bioactivity of these anti-inflammatory compounds.

Abbreviations

BAPNA:N _α-benzoyl-DL-arginine-p-nitroanilide

BYPNA:N-benzoyl-L-tyrosine-p-nitroanilide

PKA:cyclic AMP-dependent protein kinase

TLCK:N-α-p-tosyl-L-lysinylchloromethyl ketone (1-chloro-3-tosylamido-7-amino-L-2-heptanone)

TPCK:N-tosyl-L-phenylalanylchloromethyl ketone (L-(1-tosyl-amido-2-phenyl)ethylchloromethyl ketone).

References

• 1 Spence A P, Mason E B. Human Anatomy and Physiology. Benjamin/Cummings London, U.K; 1979: 465-87
• 2 Aderem A, Underhill D M. Mechanism of phagocytosis in macrophages.  Annu. Rev. Immunol.. 1999;  17 593-623
  CrossrefPubMedGoogle Scholar
• 3 Luscinskas F W, Gimbrone M A. Endothelial-dependent mechanisms in chronic inflammtory leukocyte recruitment.  Annu. Rev Med.. 1996;  47 679-705
  PubMedGoogle Scholar
• 4 Momboul J -V, Vanhoutte P M. Kinins and endothelial control of vascular smooth muscle.  Annu. Rev. Pharmacol.. 1995;  35 679-705
  PubMedGoogle Scholar
• 5 Locati M, Murphy P M. Chemokines and chemokine receptors: biology and clinical relevance in inflammation and AIDS.  Annu. Rev. Med.. 1999;  50 425-40
  CrossrefPubMedGoogle Scholar
• 6 Schindler C, Darnell J E. Transcriptional responses to polypeptide ligands : the JAK- STAT pathway.  Annu. Rev. Biochem.. 1995;  64 621-651
  PubMedGoogle Scholar
• 7 Tracey K J, Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target.  Annu. Rev. Med.. 1994;  45 491-503
  CrossrefPubMedGoogle Scholar
• 8 Wallach D, Varfolomeev E E, Malinin N L, Golstev Y V, Kovalenko A VC, Boldin  M P. Tumor necrosis factor receptor and Fas signalling mechanisms.  Annu. Rev. Immunol.. 1999;  17 331-67
  CrossrefPubMedGoogle Scholar
• 9 Balsinde J, Bolboa M A, Insel P A, Denis E E. Regulation and inhibition of phospholipase A₂ .  Annu. Rev. Pharmacol. Toxicol.. 1999;  39 175-89
  CrossrefPubMedGoogle Scholar
• 10 Bohlin L. Structure-activity studies of natural products with anti-inflammatory/immunomodulatory effects. In: Hostettmann K, Marston M, Maillard M, Hamburger M. eds Phytochemistry of Plants Used in Traditional Medicine Clarendon, Oxford, U.K; 1995: 138-63
• 11 Cronstein B N, Weissman G. Targets for anti-inflammatory drugs.  Annu. Rev. Pharmacol.. 1995;  35 449-62
  CrossrefPubMedGoogle Scholar
• 12 Geis G S. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?.  Rheumatol. 26, Suppl.. 1999;  56 31-36
  PubMedGoogle Scholar
• 13 Komaroff A L. Harvard Medical School Family Health Guide. Simon and Schuster 1999 (Ed.) New York, NY, U.S.A;
• 14 Parnham M J. Antirheumatic agents and leukocyte recruitment.  Biochem. Pharmacol.. 1999;  58 209-15
  CrossrefPubMedGoogle Scholar
• 15 Szekanecz Z, Szegedi G, Koch A E. Angiogenesis in rheumatoid arthritis: pathogenic and clinical significance.  J. Investig. Med.. 1998;  46 27-41
  PubMedGoogle Scholar
• 16 Thorn G W, Adams R D, Braunwald E, Isselbacher K J, Petersdorf R G. Harrison’s Principles of Internal Medicine. 1997, (8th edition) McGraw-Hill New York, NY, U.S.A;
• 17 Cockerill G W, Gamble J R, Vadas M A. Angiogenesis: models and modulatators.  Int. Rev. Cytol.. 1995;  159 113-60
  PubMedGoogle Scholar
• 18 Paper D H. Natural products as angiogenesis inhibitors.  Planta Medica. 1998;  64 686-95
  PubMedGoogle Scholar
• 19 Ying Q L, Rinehart A R, Simon S R, Cheronis J C. Inhibition of human leukocyte elastase by ursolic acid. Evidence for a binding site for pentacyclic triterpenes.  Biochem. J.. 1991;  277 521-6
  CrossrefPubMedGoogle Scholar
• 20 Wang B H, Polya G M. Selective inhibition of cyclic AMP-dependent protein kinase by amphiphilic triterpenoids and related compounds.  Phytochemistry. 1996;  41 55-63
  CrossrefPubMedGoogle Scholar
• 21 Hasmeda M, Kweifio-Okai G, Macrides T, Polya G M. Selective inhibition of eukaryote protein kinases by anti-inflammatory triterpenoids.  Planta Medica. 1998;  65 14-8
  PubMedGoogle Scholar
• 22 Rajic A, Kweifio-Okai G, Macrides T, Sandeman R M, Chandler D S, Polya G M. Inhibition of serine proteases by anti-inflammatory triterpenoids.  Planta Medica. 2000;  66 206-10
  Article in Thieme ConnectPubMedGoogle Scholar
• 23 Yasukawa K, Akihisa T . Anti-inflammatory and antitumor-promoting activities of sterols, triterpene alcohols and their derivatives.  Recent. Res. Devel. in Oil Chem.. 1997;  1 115-25
  PubMedGoogle Scholar
• 24 Akihisa T, Yasukawa K, Oinuma H, Kasahara Y, Yamanouchi S, Takido M, Kumaki K, Tamura T. Triterpene alcohols from the flowers of Compositae and their anti-inflammatory effects.  Phytochemistry. 1996;  43 1255-60
  CrossrefPubMedGoogle Scholar
• 25 Yasukawa K, Akihisa T, Oinuma H, Kasahara Y, Kimura Y, Yamanouchi S, Kumaki K, Tamura T, Takido M. Inhibitory effect of di- and trihydroxy triterpenes from the flowers of Compositae on 12-O-tetradecanoylphorbol-13-acetate-induced inflammation in mice.  Biol Pharm. Bull.. 1996;  19 1329-31
  PubMedGoogle Scholar

Dr. G. M. Polya

Department of Biochemistry

La Trobe University

Bundoora, Victoria 3086

Australia

Email: g.polya@latrobe.edu.au

Fax: +61-3-9479 2467